Valproate augmentation in a subgroup of patients with treatment-resistant unipolar depression

Maykel F. Ghabrash(McGill University Health Centre), Gabriella Gobbi(McGill University), Marie Saint-Laurent(McGill University Health Centre), Stefano Comai(University of Padua), Linda Booij(Centre Hospitalier Universitaire Sainte-Justine), John Tabaka(McGill University Health Centre)
The World Journal of Biological Psychiatry
October 7, 2015
10.3109/15622975.2015.1073856
Cited by 31

Related Papers

Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood
|JAMA Psychiatry|2019|911
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
|Proceedings of the National Academy of Sciences|2005|677
Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain
|Pain|2018|395
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
|Pharmacological Reviews|2018|386
Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype
|Nature Neuroscience|2006|373